Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights

NEXT STORY
Rhythm Pharmaceuticals Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Setmelanotide in POMC and LEPR Deficiency Obesities
PREV STORY
Plus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Oncternal Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

author_avatar
NASDAQ Market News

ERYTECH gibt ein Unternehmens-Update und vermeldet die Geschäftsergebnisse für das dritte Quartal 2020

author_avatar
NASDAQ Market News

Everest Medicines Completes Enrollment of Phase 3 Clinical Trial of Xerava™ (eravacycline) for the Treatment of Complicated Intra-Abdominal Infections in China

author_avatar
NASDAQ Market News